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ABSTRACT
OBJECTIVE: The objective of this selective EBM review is to determine if there is a statistically
significant difference in using combination therapies that include cryotherapy vs. cryotherapy
alone in the clearance of genital/anogenital warts.
STUDY DESIGN: Systematic review of three peer reviewed primary studies that were published
between 2009-2014.
DATA SOURCES: Review of a double-blind placebo-controlled study, a single-blinded
randomized controlled study, and a randomized clinical comparative study from 2011. All
sources were selected from PubMed based on the applicability to the clinical question and how
accurately they answered the question regarding the patient population
OUTCOMES: The outcomes of investigation were POEMs (Patient-Oriented Evidence that
Matters) that measured the overall level of clearance and partial clearance of warts.
RESULTS: On et al., showed that after 17 weeks of therapy, the combination therapy of
sinecatechins 15% ointment plus cryotherapy achieved 71% partial clearance vs. 52% on
cryotherapy alone with a p-value of 0.2037. Gilson et al., at week 4, saw a 60% clearance with
the combination of podophyllotoxin cream plus cryotherapy vs. 45% clearance of cryotherapy
alone; although, these results weren’t considered statistically significant and by week 24 the
clearance rate of either therapy was the same. Mi et al., showed a 32% clearance of anogenital
warts with both the ALA-PDT plus cryotherapy and cryotherapy alone. It also showed a 94%
clearance of genital warts with the combination therapy and a 50% clearance with the
cryotherapy alone.
CONCLUSIONS: In two of the three studies, it showed that there is a statistically significant
improvement when using the combination therapies, specifically the combination of
sinecatechins 15% ointment plus cryotherapy and the combination of ALA-PDT plus
cryotherapy.
KEYWORDS: anogenital warts, genital warts, cryotherapy

Burbano, Combination Therapies vs Cryotherapy in Treating Anogenital/Genital Warts 1

INTRODUCTION
Human papilloma virus (HPV) is a sexually transmitted disease that only infects humans
and has a 50% chance of causing an infection at least once in a person’s lifetime.1 Although the
body has the capability to clear HPV on its own, when this does not occur there are adverse
physical manifestations that arise. One of the manifestations of HPV is genital/anogenital warts;
this is the most common sexually transmitted disease and affects a large majority of the
population. This type of infection is caused by a low-grade HPV with a high rate of disease
regression, which rarely advance towards cancer.1 About 40 subtypes out of more than 120 HPV
subtypes are directly linked to anogenital warts.2 These warts increase in size over time
becoming increasingly visible and can interfere with everyday life if there is no treatment
intervention.
The number of people affected has been growing over the years and as it increases so
does the financial burden. The number of new cases can range anywhere from 500,0001,000,000 per year. As of 2012, there are as many as 20 million infected in the United States, and
this number continued to increase.2 As new patients seek treatment there is also an increase in
office visits, follow-up visits, and trial and error of medication combination. Chesson et al.
summarized that the overall cost of prevention and care of HPV in 2010 was $8 billion, of which
$300 million was directed towards genital warts.3 Beyond treatment for established infections,
HPV vaccines, including Gardasil and Cervarix, can be given to protect against this disease. In
patients that are HPV naïve, Gardasil has shown to be 99 percent effective in genital wart
prevention and long-term studies have shown that it doesn’t seem to have waning immunity.3
When a person has been infected, the symptoms may not always be severe enough to
seek treatment. Visible symptoms present 2-3 months after first contact2 and can include but
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aren’t limited to itching, burning, tenderness, and/or discomfort. Warts can present as
flat/sessile/lobular papules and can be symptomatic or asymptomatic.4 The treatment has become
disproportionately centered around the removal of visible warts rather than the actual cure of the
underlying cause. Consequently, there are no definitive treatments, but current therapies are
individualized to each patient.2 Because of this method, reoccurrence is high and depending on
the size and number of warts present, it may take several office visits to get this condition under
control.5 Without an absolute cure, the rate of persons infected will continuously increase.
There are two different approaches to the treatment of genital/anogenital warts: surgical
and non-surgical. Surgical therapies include cryotherapy, excision, electrosurgery, and laser
ablation. Non-surgical methods include podophyllin resin, podophyllotoxin cream, interferons,
ALA-PDT, trichloroacetic acid, topical photodynamic therapy using aminolevulinic acid,
sinecatechins 15% ointment, and cryotherapy. While there are many treatments that can halt the
growth or reduce the chances of reoccurrence, the therapies available can be inadequate or have
limitations that cannot treat the underlying cause. Cryotherapy alone has shown to be ineffective
against latent lesions and limited to removal of visible lesions.6 Albeit some of these modalities
only affect visible lesions, others have a stronger effect on latent infections or can reduce the
amount of sessions needed for clearance. Although there are some benefits to using cryotherapy,
the limitations from a single modality have caused the need for further research into combination
treatments. Combination therapies have been demonstrated to affect latent lesions, can be used as
at-home treatment, and have been shown to have an earlier onset of action.4,5,6 With so many
possible methods for treatment, patients have a variety of options that can cater to their specific
type of infection.

Burbano, Combination Therapies vs Cryotherapy in Treating Anogenital/Genital Warts 3

As previously mentioned, genital/anogenital warts can have a negative impact on a
person’s intimate life. Although the main concern is the visibility of the wart, accompanying
symptoms such as itching, pain/bleeding with intercourse, and the possibility of warts in the
mouth/throat when in contact with an infected person4 are reasons to look for an alternative
treatment.
OBJECTIVE
The objective of this selective EBM review is to determine whether or not there is a
greater statistically significant difference in the clearance or partial clearance of
genital/anogenital warts when it comes to combination therapies that include cryotherapy vs
cryotherapy alone.
METHOD
All sources were searched and selected from PubMed. The three studies used in this
review were 3 randomized, single/double blinded and comparative studies comparing
combination therapies that included cryotherapy vs. cryotherapy alone in the complete/partial
clearance of genital/anogenital warts. The patient population consisted of males and females ages
18 and above that had either anogenital or genital warts. The interventions included
sinechatechins 15% ointment plus cryotherapy, podophyllotoxin plus cryotherapy, and
photodynamic therapy plus cryotherapy. All these interventions were in comparison to the
control group, cryotherapy. The outcomes of these EBM studies were focused around the overall
level of clearance and partial clearance of warts.
The key words that were used in the selection of these articles through PubMed included:
cryotherapy, genital warts, and anogenital warts. These peer-reviewed articles were published in
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English and publication took place within the last 10 years. The selection was based on their
applicability and how accurately they answered the question regarding the patient population.
The statistics reported consisted of Chi-square, Fisher’s exact test, ANCOVA model, Cochran,
and the Mantel-Haenszel test. A more descripted inclusion and exclusion criteria is explained
below in Table 1.
Table 1. Demographics and characteristics of included studies
Study

Type
RCT

# of
pts
42

Age
(yrs)
>18

On,
2014

Gilson,
2009

RCT

149

1870

Mi,
2011

randomized 109
clinical
comparative
study

1854

Inclusion
criteria
2 or more
clinically
typical,
visible warts;
negative
pregnancy
tests and use
of approved
method of
birth control
throughout
duration of
study
At least 2
external
anogenital
warts that
could be
appropriately
treated
At least 3
(max of 30)
anogenital
warts or one
larger than
0.5 cm (max:
2 cm)

Exclusion criteria

W/D

Interventions

Hx of herpes
genitalis, HIV,
hepatitis B and C, hx
of organ allograft,
and/or internal warts
requiring tx. Recent
tx, within 90 days,
or dermatologic
procedures that
could interfere with
the evaluation of
current tx

9

Sinecatechins
15% ointment
plus
cryotherapy vs
cryotherapy

HIV positive,
concurrent internal
anogenital warts,
warts > than 4 cm2

13

Podophyllotoxin
cream plus
cryotherapy vs
cryotherapy

Infected with other
sexually transmitted
ds, had
immunosuppression,
were pregnant or
breast feeding, or
had concurrent intraanal or intra-vaginal
warts

29

Photodynamic
therapy plus
cryotherapy vs
cryotherapy
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OUTCOMES MEASURED
The outcomes were patient oriented (POEMs) and were determined based on the
reoccurrence of warts, and the comparison between complete vs. partial clearance. On et al., used
chi-squared test to compare partial. Gilson et al., used observed data and last observation carried
forward (LOCF) in patients that didn’t follow-up according to their schedule. Mi et al., used
Cochran and the Mantel-Haenszel test to evaluate the recurrences of warts and number of
completed responses.
RESULTS
All three studies tested methods that would decipher whether a combination therapy or
cryotherapy alone would result in a better outcome in genital/anogenital warts. Each systematic
review consisted of either a double-blind placebo-controlled study, a single-blinded randomized
controlled study, or a randomized clinical comparative study. About 20% loss to follow up was
experienced in the study consisting of podophyllotoxin cream plus cryotherapy. In the study
including sinecatechins 15%, only 2 patients were lost to follow-up. In all three studies, all the
patients were randomly placed into either the experimental or control group and all evaluators
remained blinded during examination of the lesions. Adverse effects were limited to erythema,
scaling, irritation, mild to moderate pain, hypopigmentation, soreness, and in no study did
patients withdrawal due to severity of adverse effects.4,5,6
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Table 2. Treatment effect comparison in ITT population regarding partial clearance4
sinecatechins 15%
ointment plus
cryotherapy (n=21)
7 (33.3%)

Cryotherapy alone
(n=21)

*P-value

6 (28.6%)

p = 0.7385

9 (42.9%)

p = 0.0614

11 (52.4%)

p = 0.2037

Week 1
n (%) cleared
Week 9
15 (71.4%)
n (%) cleared
Week 17
15 (71.4%)
n (%) cleared
* p-values calculated using Chi squared

On et al. conducted a study where 42 patients underwent cryotherapy treatment as a
baseline and after one week two groups were divided between the experimental group,
sinecatechins 15% ointment, and the control group, cryotherapy alone. Both groups had an
average range of 8.3 – 9.8 lesions. Subjects were to have at least 2 or more visible warts and
were expected to continue treatment for 17 weeks or until complete clearance of warts.4 On et
al., defined complete clearance as having zero lesions and partial clearance was defined as
having 50% reduction from baseline. At the end of week 17, the resulting p > 0.05 indicated the
outcome regarding partial clearance was not statistically significant even though the trend
favored the combination therapy.
Table 3. Anogenital wart clearance; ITT analysis using LOCF5

Week 4
n (%) cleared

Week 12
n (%) cleared

Podophyllotoxin
combination
(n=70)

Cryotherapy
alone
(n=70)

Unadjusted OR
(95% CI)
------------P-value

Adjusted OR
(95% CI)
------------P-value

42 (60.0)

32 (45.7)

1.78 (0.91 to 3.48)

1.99 (0.91 to 4.36)

p = 0.09

p = 0.085

1.78 (0.91 to 3.48)

1.94 (0.95 to 3.97)

p = 0.09

p = 0.069

42 (60.0)

32 (45.7)
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Gilson et al. conducted a multicentre, randomized, double-blind, placebo-controlled study
with patients stratified by sex and history of anogenital warts. Patients were divided into two
groups of 70. The experimental group was composed of podophyllotoxin plus cryotherapy, and
control group was composed of cryotherapy alone. The effectiveness of podophyllotoxin was
investigated by percentage of clearance and exploratory analysis regarding wart history and wart
type.5 There were two major endpoints, at 4 and 12 weeks, when studying podophyllotoxin
cream plus cryotherapy. While the most research is evaluated by these two endpoints, there were
still data collected until 24 weeks on a voluntary basis. Even though the overall clearance was
higher (60%) with the combination therapy at both endpoints than cryotherapy alone (45.7%) it
wasn’t enough to be considered statistically significant due to the p-value being greater than 5%.
During the 4th week there was a higher clearance rate in patients that had warts before (p = .009)
vs. those who have never had warts before although there was no significant finding between the
two groups at the 12-week mark.5 Between the keratotic and non-keratotic warts, there was no
difference in clearance at week 4 or 12. The adjusted odds ratio takes into account the baseline
number and area of warts, history and treatment center.5
Table 4. Difference in the clearance or partial clearance of anogenital/genital warts when it
comes to combination therapies that include cryotherapy versus cryotherapy alone
Study
On et al.
complete
clearance
On et al. partial
clearance
Gilson et al.
complete
clearance

Control event rate
(CER)
.286

Experimental
event rate (EER)
.286

Absolute benefit
increase (ABI)
0

Numbers needed
to treat (NNT)
N/A

.429

.714

.190

4

.457

.600

0.143

7
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On et al. study showed there is no increased therapeutic outcome in using the
combination treatment over the monotherapy regarding complete clearance. This study also
showed that for every 4 patients treated with sinecatechins plus cryotherapy, one more will have
clearance of at least 50% than if treated with cryotherapy alone. Gilson et al. showed that for
every 7 patients treated with combination therapy, one more person will have overall clearance
than if treated with cryotherapy alone.
Table 5. Response rate in patients after 1 and 2 treatments of cryotherapy plus ALA-PDT or
cryotherapy6
Cryotherapy plus ALA-PDT
Number of lesions in the anal
area
Response rate after one
treatment
Response rate after two
treatments
Number of lesions in the
external genitals
Response rate after one
treatment
Response rate after two
treatments

111

Cryotherapy plus placeboPDT
132

18.9%

18.2%

32.4%

32.6%

137

111

73.7%

38.7%

94.2%

50.5%

Mi et al. conducted a randomized clinical comparative study with 40 patients that
received the combination of ALA-photodynamic therapy (PDT) plus cryotherapy and 40 patients
that received cryotherapy alone. ALA-PDT disrupts the target cell by the build-up of ALAinduced protoporphyrin IX in cells that are increasing in number.6 Mi et al. states based on the
Pearson chi-squared test and the t-test there was no statistically significant differences in the
initial number of warts between the experimental and the control group. Table 5 shows a higher
response rate in the treatment of genital warts with the combination therapy and the response rate
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of anogenital warts clearance is about the same with both, cryotherapy alone and the
combination therapy. Table 5 shows that after multiple treatments the clearance is higher in
genital warts with the combination of cryotherapy plus ALA-PDT and no statistically significant
improvement in the treatment of anogenital warts. Anogenital warts resulted in a p>0.05 after
both treatments and a p< 0.05 in external genital area after both treatments.6 The response rates
of genital/anogenital warts regarding each treatment utilized is explained in tables 5.
DISCUSSION
Genital/anogenital warts is a sexually transmitted disease caused by HPV that infects the
body through a break in the skin or the mucosa when there is skin-to-skin contact or mucosa-tomucosa contact.1 Cryotherapy has long been a common modality in the treatment of warts.
Unfortunately, its limitations cause researchers to look for alternative treatments with better
results. Ideal alternatives would treat the underlying condition.
Each research study described several ways to increase accuracy in their results.
Sinecatechins 15% ointment could have been better reviewed with a larger sample size.
Outcomes could have been affected by participants practicing unsafe sex or they may have not
reported all sexual partners.4 Gilson et al., also expressed a larger sample size could determine
whether or not the effects of podophyllotoxin cream with cryotherapy was actually superior to
cryotherapy alone. Factors that could’ve affected the outcome include patients being able to selfasses and more patients in the podophyllotoxin combination arm stopped blinded study
medication than in cryotherapy alone5. Mi et al. described a major limitation in the follow-up
time. Follow-up was limited to 12 weeks and reoccurrence can be known to occur up to a year
out.6 One of the limitations of the cryotherapy plus photodynamic therapy vs. cryotherapy is part
of their exclusion criteria did not include those that were recently treated, if applicable. In two of
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the studies, it was not made clear if they had tested for latent lesions. The study including
podophyllotoxin cream plus cryotherapy was done in the United Kingdom and the combination
was shown to have increase pain/soreness, so patient compliance would come into question.5
Even with addressing these limitations there are always going to be uncontrollable factors such
as patient compliance and reaction to medication that will inevitably cause meeting accuracy
challenging.
This EBM review was meant to evaluate 3 studies comparing different combination
therapies that included cryotherapy vs. cryotherapy alone in the complete/partial clearance of
genital/anogenital warts. Even though the results were favoring the combination therapy of
sinecatechins 15% ointment plus cryotherapy, the data stated that the results were not statistically
significant regarding partial clearance based on the p-value reported. In the review of
podophyllotoxin cream plus cryotherapy, the results remained constant with slightly favorable
results with the combination therapy, although not statistically significant even when adjusted for
baseline number and area of warts, history and treatment center differences between the groups.5
In the review of photodynamic therapy plus cryotherapy, the clinical results favored the
combination therapy response rate over cryotherapy alone in the treatment of external genital
warts after both treatments.
CONCLUSION
All three studies have shown both combination therapies and cryotherapy alone have the
capability of clearing anogenital/genital warts to an extent. The results in the study involving
photodynamic therapy and cryotherapy favored the combination treatment. The studies involving
sinecatechins 15% plus cryotherapy and podophyllotoxin plus cryotherapy favored cryotherapy
alone. Although one portion of one of the studies favored combination therapy, there is not
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enough evidence to ultimately conclude that combination therapies have a greater statistical
difference in the clearance or partial clearance of anogenital/genital warts. Further research needs
to be done since this is the first time the combination of photodynamic therapy plus cryotherapy
has been studied and would benefit from expanding the exclusion criteria such as recent
treatment and dermatological treatments that could interfere with results. All three of these
combination therapies have not been properly evaluated before4,5,6 and with decreased limitations
in future research, better outcomes can be achieved.
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